点击显示 收起
ISAB - Unity QUASH
Laboratory of Nutritional Genomics
BP.30313
Rue Pierre Waguet
60026-Beauvais
France
E-mail: abalo.chango{at}isab.fr
Faculty of Medicine
Laboratory of Medical Biochemistry
Vandoeuvre-Les-Nancy
France
Jerome Lejeune Institute
Paris
France
Dear Sir:
The reduced folate carrier gene (RFC1 or SLC19A1) located on chromosome 21 (21q22.3) codes for the reduced folate carrier, which is responsible for 5-methyltetyrahydrofolate internalization within cells. We published earlier the 80GA single-nucleotide polymorphism (SNP) in human reduced folate carrier cDNA and hypothesized that it influences folate metabolism or the plasma total homocysteine concentration (1). The SNP 80GA polymorphism (rs1051266; http://www.ncbi.nlm.nih.gov at the SNP database) is a guanine-to-adenine exchange at nucleotide 80 in RFC1 cDNA. Because of the extra copy of chromosome 21 in persons with trisomy 21, or Down syndrome, a dosage effect of RFC1 and a functional effect of the SNP 80GA polymorphism may contribute to a imbalance of one-carbon-derived metabolites and DNA methylation. Allelic ratios are 3:0, 2:1, 1:2, and 0:3 for the 80GGG, 80GGA, 80GAA, and 80AAA genotypes, respectively, in trisomy 21 compared with 2:0, 1:1, and 0:2 for the 80GG, 80GA, 80AA genotypes, respectively, in control subjects.
In a study published in this issue of the Journal, we analyzed the 80G
FIGURE 1.. Quantification of the reduced folate carrier 80GA single-nucleotide polymorphism (SNP) by pyrosequencing. The sequence to be analyzed was GGCA/GCCT. The sequencing primer was 5'-CTC CGG TCC TGG C. The SNP position was denoted A/G when entered in the PSQ 96MA software (Pyrosequencing AB, Uppsala, Sweden). The T and A at the first and sixth positions, respectively (TGCA/GACCTC), were used as controls that should not bind to the DNA template and therefore should not result in a peak; the appearance of small peak heights at these positions is an indication of background in the assay. High peak heights at the G and C positions indicate the presence of the same adjacent nucleotide (GG or CC).
The pyrosequencing results of our initial samples (2) show that among the persons with trisomy 21, 37 persons (23.7%) were homozygous 80GGG, 52 persons (33.5%) were heterozygous 80GGA, 44 persons (28.4%) were heterozygous 80GAA, and 22 persons (14.2%) were homozygous 80AAA. Among the control subjects, the numbers of subjects were as follows: 53 persons (33.4.%) were homozygous 80GG, 74 persons (46.5%) were heterozygous 80GA, and 32 persons (20.0%) were homozygous 80AA. In conclusion, genotyping SNP and determination of allele frequency in trisomy need specific techniques based on allele quantification. Pyrosequencing is an appropriate technique that allows one to distinguish heteroallelic individuals containing 1 or 2 copies of each allele.
ACKNOWLEDGMENTS
Funded by the Jerome Lejeune Foundation, Paris. We are grateful to Severine Barry-Charret and Severine Ferre for expert laboratory analysis.
AC was the principal investigator and was responsible for developing the pyrosequencing technique and writing the manuscript. NFE contributed to collecting samples and analyzing the laboratory data. HB was the initial protocol designer responsible for collecting and managing the patients and samples during the study. JPN was the co-principal investigator and is the head of the medical biochemistry research group. FW developed the Agrohealth research program in the ISAB. None of the authors had any conflicts of interest.
REFERENCES